← Leaderboards
Michelle Hernandez
Univ Of North Carolina Chapel Hill
$5,990,343
Attributed
$8,420,208
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,420,208 · 4
By mechanism
K12$4,859,730 · 1
R01$2,715,534 · 1
K23$611,694 · 1
R34$233,250 · 1
Top collaborators
- Jonathan J Juliano3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Samir Kelada$10,045,007
- Lauren Donoghue$100,209
- Theo Beltran$80,742
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaAdrenal Cortex HormonesRandomizedRecruitPlacebosInflammatoryInflammationProductionMorbidity - Disease RateAcuteNeutrophil InfiltrationAirway InflammationPharmaceutical PreparationsHealthy VolunteerCytokineAllergicExposure ToNeutrophilFutureHourLung DiseasesMediatingLiteratureAllergic Airway Inflammation
Grant awards (12)
CTSA K12 Program at UNC$1,620,000
K12 · FY2025 · TR · contact PI
Rescue anakinra treatment for moderate asthma attacks$233,250
R34 · FY2025 · HL · contact PI
CTSA K12 Program at UNC$1,619,730
K12 · FY2024 · TR · contact PI
CTSA K12 Program at UNC$1,620,000
K12 · FY2023 · TR · contact PI
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans$301,726
R01 · FY2021 · HL · contact PI
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans$603,452
R01 · FY2020 · HL · contact PI
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans$603,452
R01 · FY2019 · HL · contact PI
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans$603,452
R01 · FY2018 · HL · contact PI
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans$603,452
R01 · FY2017 · HL · contact PI
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2$203,898
K23 · FY2014 · ES · contact PI
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2$203,898
K23 · FY2013 · ES · contact PI
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2$203,898
K23 · FY2012 · ES · contact PI